Latest Morning Briefing Stories
KHN’s ‘What the Health?’: Georgia Turns the Senate Blue
Democratic victories in two runoff elections in Georgia will give Democrats control of the Senate starting Jan. 20, which means they will be in charge of both houses of Congress and the White House for the first time since 2010. Meanwhile, covid continues to run rampant while vaccine distribution lags. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
San Francisco Wrestles With Drug Approach as Death and Chaos Engulf Tenderloin
Covid-19, distrust of police and cheap narcotics have turned parts of the wealthy city into cesspools of filth and drug overdose. City officials and residents profoundly disagree on what needs to be done.
Listen: How Operation Warp Speed Became a Slow Walk
KHN Editor-in-Chief Elisabeth Rosenthal discusses the bottlenecks in distributing covid vaccines on NPR’s “On My Mind” podcast with host Diane Rehm.
Many Health Plans Now Must Cover Full Cost of Expensive HIV Prevention Drugs
Most private insurance will be required to cover drugs, like Truvada, that offer protection against HIV infection, without making plan members share the cost.
Children’s Hospitals Are Partly to Blame as Superbugs Increasingly Attack Kids
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail seniors but are increasingly infecting kids. And the pandemic is making things worse.
Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets
While many private insurers cap what members pay in health costs, Medicare does not. Democrats and Republicans in Congress have proposed annual limits ranging from $2,000 to $3,100. But there’s disagreement about how to pay for that cost cap.
Analysis: Some Said the Vaccine Rollout Would Be a ‘Nightmare.’ They Were Right.
There are already signs that the distribution of the COVID vaccines will be messy, confusing and chaotic.
KHN’s ‘What the Health?’: 2020 in Review — It Wasn’t All COVID
The coronavirus pandemic colored just about everything in 2020. But there was other health policy news that you either never heard or might have forgotten about: the Affordable Care Act going before the Supreme Court with its survival on the line; ditto for Medicaid work requirements. And a surprise ending to the “surprise bill” saga. Joanne Kenen of Politico, Anna Edney of Bloomberg News and Sarah Karlin-Smith of Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine
Months before federal officials authorized experimental vaccines to ward off the coronavirus in humans, scientists tried a veterinary vaccine in endangered ferrets. Drugmakers are researching similar efforts for other animals proving vulnerable to the virus, such as farmed minks, in part to guard against virus mutations that could pose new risks to people.
Inside the First Chaotic Days of the Effort to Vaccinate America
After missteps in Washington, each state and county is left to juggle where to send vaccines first and how to get them to each nursing home, hospital local health department and even school.
Agrícolas, bomberos y azafatas buscan estar entre los primeros en recibir la vacuna
Trabajadores de salud de primera línea, y residentes y personal de hogares de adultos mayores, recibirán las dosis de la vacuna contra COVID primero, pero… ¿quiénes le seguirán?
Supply Is Limited and Distribution Uncertain as COVID Vaccine Rolls Out
Hospitals and nursing homes must decide who gets the initial doses as the U.S. heads into the biggest vaccination effort in history. There’s a lot left to figure out.
Farmworkers, Firefighters and Flight Attendants Jockey for Vaccine Priority
Everyone — from toilet paper manufacturers to patient advocates — is lobbying state advisory boards, arguing their members are essential, vulnerable or both — and, thus, most deserving of an early vaccine.
Demand for COVID Vaccines Expected to Get Heated — And Fast
With two vaccines against coronavirus disease poised for release within weeks, experts say they expect attitudes to shift dramatically from hesitancy to “Beanie Baby”-level urgency.
Feds Look to Pharmacists to Boost Childhood Immunization Rates
Fears over COVID-19 have contributed to a slump in inoculations among children. Now the federal government is looking to pharmacists for help, but many of them do not participate in a program that offers free shots to half the kids in the U.S.
Cómo COVID-19 resalta la incertidumbre de las pruebas médicas
Según estimaciones, estas pruebas tienen una tasa de falsos negativos de hasta el 30%, es decir que 3 de cada 10 personas que realmente tienen la infección darán negativo.
How COVID-19 Highlights the Uncertainty of Medical Testing
Widespread COVID testing has revealed uncomfortable truths about medical tests: A test result is rarely a definitive answer, but instead a single clue. A result may be falsely positive or negative, or it may show an abnormality that doesn’t matter. And as COVID testing has made too clear, even an accurate, meaningful result is useless unless it’s acted on appropriately.
How Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID
A Trump administration maneuver allows executives who are leading the federal effort to keep investments in drug companies that would benefit from the pandemic response.
New Legal Push Aims to Speed Magic Mushrooms to Dying Patients
A proposal in Washington state would use right-to-try laws to allow terminally ill patients access to psilocybin — the famed magic mushrooms of America’s psychedelic ’60s — to ease depression and anxiety.
Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs
A provision the Trump administration tucked into its final rule on health plan price transparency requires telling consumers what they will pay out-of-pocket for drugs and showing them what the plan paid.
